Startups

Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.

Summary

Seedtable Score
  • 17
Locations
Company Size
  • 11 to 50 employees
Last Stage Round
  • Series A

Total funding Amount

$40M

Fundraising History

  • Oct 01 '22 Series A
    $30M
  • Jun 01 '21 Seed
    $9.6M
  • Mar 01 '20 Pre Seed
    $150K

Investors

  • Khosla Ventures
    Seed
  • BACKED VC
    Seed
  • Norrsken VC
    Series A
  • Hoxton Ventures
    Seed
  • Apollo Health Ventures
    Seed
  • Y Combinator
    Pre Seed